Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Youdao (DAO) Research & Development (2018 - 2025)

Youdao has reported Research & Development over the past 8 years, most recently at -$20.4 million for Q4 2025.

  • Quarterly Research & Development fell 23.36% to -$20.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$72.2 million through Dec 2025, up 3.7% year-over-year, with the annual reading at $73.5 million for FY2025, 0.6% down from the prior year.
  • Research & Development was -$20.4 million for Q4 2025 at Youdao, down from -$18.0 million in the prior quarter.
  • Over five years, Research & Development peaked at -$15.9 million in Q1 2025 and troughed at -$32.0 million in Q1 2022.
  • The 5-year median for Research & Development is -$24.7 million (2023), against an average of -$23.9 million.
  • Year-over-year, Research & Development plummeted 115.48% in 2021 and then soared 33.62% in 2024.
  • A 5-year view of Research & Development shows it stood at -$26.7 million in 2021, then rose by 2.6% to -$26.0 million in 2022, then rose by 8.99% to -$23.7 million in 2023, then skyrocketed by 30.18% to -$16.5 million in 2024, then fell by 23.36% to -$20.4 million in 2025.
  • Per Business Quant, the three most recent readings for DAO's Research & Development are -$20.4 million (Q4 2025), -$18.0 million (Q3 2025), and -$17.9 million (Q2 2025).